Israeli team develops ‘anti-diabetes drug’
Thursday, January 16, 2020 | Tag Cloud Tags: Israel, Jerusalem, News, Worthy News | Learn about our FREE SYNDICATION Service | Sign up for our Worthy Briefs!
(Worthy News) – A new drug being developed in Israel could be the answer to treating the main cause of Type 2 Diabetes, insulin resistance.
According to Concenter BioPharma co-founder and CSO Prof. Mottie (Mordechai) Chevion, “the unique property” of the drug, called Zygosid-50 “is that it cancels out insulin resistance.
“It’s an anti-diabetes drug,” he told The Jerusalem Post during an interview on Thursday afternoon. [ Source: Jerusalem Post (Read More…) ]
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.